Abstract
In order to overcome difficulties that hampered widespread application of antiangiogenesis in cancer therapy, a highly specific delivery system may be engaged in vivo to deliver and express antiangiogenic genes. We selected a strain of Bifidobacterium adolescentis (B. adolescentis) as the delivery system to transport endostatin gene to solid tumors. B. adolescentis with endostatin gene were injected into tumor-bearing mice through the tail vein. After the mice were sacrificed, the tumor and some normal tissues of the mice were examined. B. adolescentis were only found in the tumors and no bacilli were found in other normal tissues. Also, a strong inhibition of angiogenesis had been shown to inhibit local tumor growth in the administrated group. These results suggested that B. adolescentis only germinated and proliferated in solid tumors and might be a highly specific and efficient vector for transporting anticancer genes into target tumor in cancer gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kandel J, Bossy-Wetzel E, Radvany F, et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 1991;66:1095–1104.
O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328.
O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285.
O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689–692.
Fan YR, Xu GX, Liu XJ, et al. Construction of a recombinant human endostatin/MBP fusion protein and study on its antitumor effects in vitro and in vivo. Chin Cancer Biother. 2000;7:150–151.
Li X, Xu GX, Wang JJ . Construction of recombinant human endostatin/MBP fusion protein and its segments and their inhibition on endothelia proliferation in vitro. Chin J Cell Biol. 2001;23:91–95.
Dachs GU, Patterson AV, Firth JD, et al. Targeting gene expression to hypoxic tumor cells. Nat Med. 1997;3:515–520.
Kimura NT, Taniguchi S, Aoki K . Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res. 1980;40:2061–2068.
Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 2000;7:269–274.
Lin PF . Antitumor effect of Actinidia chinensis polysaccharide on murine tumor. Chin J Oncol. 1988;10:441–444.
Scharek L, Hartmann L, Heinevetter L, et al. Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium, Bacteroides thetaiotaomicron, in gnotobiotic rats. Immunobiology. 2000;202:429–441.
Argnani A, Leer RJ, van Luijk N, et al. A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium. Microbiology. 1996;42:109–114.
Zhang ZQ, Yao LH, Hou YD . Construction and application of a high level expression vector containing PRPL promotor. Chin J Virol. 1990;6:111–116.
Park MS, Lee KH, Ji GE . Isolation and characterization of two plasmids from Bifidobacterium longum. Lett Appl Microbiol. 1997;25:5–7.
Chen J, Jin K, Chen M, et al. Early detection of DNA strand breaks in the brain after transient focal ischemia: implication for the role of DNA damage in apoptosis and neuronal cell death. Neurochemistry. 1997;69:232–245.
Yasui H, Ohwaki M . Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci. 1991;74:1187–1195.
Reddy BS, Rivenson A . Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f] quinoline, a food mutagen. Cancer Res. 1993;53:3914–3918.
Chen QR, Dhruv K, Sanford AS, et al. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 1999;59:3308–3312.
Sauter BV, Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA. 2000;97:4802–4807.
Nguyen JT, Wu P, Clouse ME, et al. Adeno-associated virus–mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res. 1998;58:5673–5677.
Harsharnjit SG, Kay JR, Martin LC, et al. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001;74:833–839.
Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046–1049.
Walter P . Effects of vegetarian diets on aging and longevity. Nat Rev. 1997;55:S61–S65.
Kikuchi-Hayakawa H, Onodera N, Matsubara S, et al. Effects of soy milk and Bifidobacterium fermented soy milk on lipid metabolism in aged ovariectomized rats. Biosci Biotechnol Biochem. 1998;62:688–1692.
Singh J, Rivenson A, Tomita M, et al. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 1997;18:833–841.
Acknowledgements
This work was supported by Grant BK20000001 from the Natural Science Foundation of Jiangsu Province, China, to GXX; Grant 30070250 from the National Natural Science Foundation of China; and a Grant-in-aid of “985 Project” from the Nanjing University to JJW. We thank Yan Chen (New York University School of Medicine) for reading this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, X., Fu, GF., Fan, YR. et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther 10, 105–111 (2003). https://doi.org/10.1038/sj.cgt.7700530
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700530
Keywords
This article is cited by
-
Engineered live bacteria as disease detection and diagnosis tools
Journal of Biological Engineering (2023)
-
Anticancer effects of bifidobacteria on colon cancer cell lines
Cancer Cell International (2021)
-
Feasibility between Bifidobacteria Targeting and Changes in the Acoustic Environment of tumor Tissue for Synergistic HIFU
Scientific Reports (2020)
-
Engineering the gut microbiota to treat chronic diseases
Applied Microbiology and Biotechnology (2020)
-
The role of bacteria in cancer therapy – enemies in the past, but allies at present
Infectious Agents and Cancer (2018)